News

Medical societies have firmly established seed implantation in their guidelines for around 20 years. Now the Federal Joint Committee (G-BA) has followed suit and finally given the green light for this modern procedure. In its decision, the committee certifies that LDR brachytherapy for localized prostate cancer is of great benefit and has fewer side effects than surgery.

Radical removal of the prostate leads to permanent urinary leakage (incontinence) in a significant percentage of prostate cancer patients. This again emerges from a subgroup analysis of the large-scale ProtecT study published in 2020 in the renowned journal European Urology.

Second tumors on the bladder or rectum do not occur more frequently after brachytherapy than after radical removal of the prostate. This is one of the findings of a large-scale study by the British Columbia Cancer Agency.

The Urology Department in the KLINIK am RING has successfully passed the quality certification according to the new DIN EN ISO 9001 standard again this year.

EAU Congress: radical removal of the prostate leads to erectile dysfunction in a significant percentage of patients even with nerve-preserving surgery.

Radiation or surgery for prostate cancer? With no other cancer do opinions differ so widely.

JAMA study: brachytherapy combined with external beam radiation achieves better outcomes for patients with "high-risk" prostate cancer than surgical removal of the prostate.

The international Prostate Cancer Results Study Group (PCRSG) has developed a unique decision aid to compare the cure rates of all modern therapies, depending on the risk profile of the tumor.

ProtecT study shows: patients after prostate surgery suffer most from consequences of treatment.

A recently published study again confirmed the excellent efficacy of brachytherapy: Ten years after treatment, the biochemical recurrence-free rate was significantly better in patients who received seed implantation than in patients whose prostates were surgically removed.

The IQWiG Institute has rejected the early detection of prostate cancer using the PSA test. The Institute has been sharply criticized by the German Society of Urology (DGU). "Rightly so," say Dr. Stephan Neubauer and Dr. Pedram Derakhshani of the West German Prostate Center in Cologne.

Many of you are uncertain in times of Corona, and rightly so. You ask yourself and us the question whether you should have currently planned interventions or examinations on the prostate or postpone them for the time being. We at the West German Prostate Center can help you!